Why the study?
Are anticholinergic burden scores from different risk scales associated with adverse clinical outcomes in older people?
Are anticholinergic burden scores from different risk scales associated with adverse clinical outcomes in older people?
Despite substantial differences in how nine different scales estimate anticholinergic burden, all are associated with adverse clinical outcomes in older people.
Answers are grounded in this paper and cite their sources.
Anticholinergic burden scores may aid risk stratification in older adults; leaves open optimal scale selection and prospective validation.
There are substantial differences in the estimation of anticholinergic burden exposure between the nine scales. Anticholinergic burden scores obtained from each of the scales were associated with adverse clinical outcomes of interest.
No takes yet. Share an insight, caveat, or question.
Salahudeen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: